← Evidence map

ArticleReports (MDPI)2025

Osimertinib-Induced Hepatitis Following Immunotherapy in a Patient with Lung Adenocarcinoma Harboring De Novo EGFR Exon 19 Deletion and T790M Mutations: A Case Report.

Bradley Steiner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Osimertinib-Induced Hepatitis Following Immunotherapy in a Patient with Lung Adenocarcinoma Harboring De Novo EGFR Exon 19 Deletion and T790M Mutations: A Case Report. | OpenQuestion